INDICES
  • Samba 65 00% 56.65%
    Joga2002 635.254 50% 63.63%
    Bra52 69 23.145% -63.25%
    Joga2002 635.254 50% 63.63%
  • HangSang20 370 400% -20%
    NasDaq4 33 00% 36%
    S&P5002 60 50% 10%
    HangSang20 370 400% -20%
    Dow17 56.23 41.89% -2.635%
-

EghtesadOnline: Teriparatide (a prescription medicine used to treat osteoporosis) has been removed from the list of medicines covered by insurance for 45 days now, the head of Iranian Rheumatology Association, Ahmadreza Jamshidi, said.

“Seven thousand patients have been suddenly denied insurance coverage of teriparatide, which is the only prescription medicine used to treat severe osteoporosis,” he said. “Teriparatide treatment’s duration for patients with osteoporosis is 18 to 24 months. Imagine a patient who has been on this drug for six months and now cannot afford to complete its expensive treatment,” he added. Without insurance coverage, patients have to pay ten times more, ILNA quoted a patient suffering from osteoporosis as saying.

 

Iran Osteoporosis Medication Iran Osteoporosis Iran Teriparatide